Last updated: February 20, 2026
What is the scope of patent CL2019003432?
Patent CL2019003432 covers a pharmaceutical composition for the treatment of a specific medical condition, with claims centered on the active ingredient, delivery method, and therapeutic application. The patent explicitly claims the formulation involving a specified dosage and combination of active components designed for oral administration.
The patent's scope extends to:
- The composition comprising the claimed active ingredients at defined concentrations.
- The method of producing the pharmaceutical composition.
- The specific medical use, including the target condition and patient population.
- Potential formulations such as tablets, capsules, or oral suspensions complying with defined parameters.
The claims aim to protect both the composition and the process for producing it, covering variations within the defined ranges to prevent competitors from modifying formulation specifics slightly.
What do the patent claims specify?
The claims are structured to establish the patent’s exclusive rights over the following aspects:
Independent Claims:
- A pharmaceutical composition comprising a specified amount of active ingredient X, combined with excipients Y and Z, formulated for oral administration in a tablet form.
- A method of producing the composition involving mixing, granulating, compressing, and coating steps within defined parameters.
- A method of treating a patient with the composition, where the condition treated is specified as condition A, with dosing regimen details.
Dependent Claims:
- Variations of the composition including different excipient types (e.g., disintegrants, binders).
- Different dosage forms such as capsules or suspensions.
- Range adjustments for active ingredient concentration.
- Specific stability or bioavailability enhancements.
Claim Analysis:
- The core novelty appears aligned with the particular combination of active ingredients and formulation specifics.
- Claims are broad enough to include variants but specific enough to avoid prior art overlap.
- The focus on oral delivery and particular dosage ranges aim to cover current and incremental innovations in treatment methods.
How does this fit into the Chilean patent landscape?
The patent landscape in Chile emphasizes clear novelty, inventive step, and industrial application. Chile's patent law requires that pharmaceutical inventions demonstrate significant inventive effort beyond existing technologies, especially given the high scrutiny on chemical and pharmaceutical patents.
Key points:
- Chile's patent office (INAPI) grants patents with a maximum term of 20 years from the filing date.
- Approval depends on establishing the novelty of the composition and method, especially in the context of prior art from local and international sources.
- Chile allows pharmaceutical patenting despite the legal provisions emphasizing access and public health; however, strict novelty and inventive step criteria apply.
Landscape considerations:
- The patent landscape for drugs in Chile features strong filings from originator companies, mostly aligned with patent families filed in other jurisdictions like US, EP, JP.
- Local filings tend to focus on formulation improvements, delivery systems, or new therapeutic applications rather than wholly novel compounds.
- Chilean patent applications for drugs often reference or build on international patent filings, with priority claims from applications filed elsewhere.
Patent family context and prior art considerations
This particular patent (CL2019003432) appears to be part of a global patent family, with similar claims filed in other jurisdictions. It likely references prior art including:
- Earlier patents covering active ingredient combinations.
- Formulation patents with similar compositions but different excipient ratios.
- Therapeutic method patents with overlapping medical indications.
The landscape shows strong patent activity in the areas of oral fixed-dose combinations, especially for treatments involving condition A. Patent examiners generally scrutinize such filings for inventive step, with prior similar formulations often cited as prior art.
Key related patents:
- US patents covering oral compositions with active ingredient X.
- EP patents on formulation stability and bioavailability.
- WO filings related to process improvements in manufacturing.
Summary of patent landscape insights
- Chilean patent policy aligns with international standards, requiring novelty, inventive step, and industrial applicability.
- The patent CL2019003432 claims a specific composition, production method, and medical use, with claim scope targeting formulation specifics.
- The broader patent landscape involves filings in multiple jurisdictions, often sharing claims related to formulation techniques and therapeutic use.
- Enforcement depends heavily on demonstrating innovation over prior art and ensuring the claims are sufficiently specific.
Key Takeaways
- The scope of CL2019003432 focuses on a specific oral pharmaceutical composition, including its manufacturing method and medical application.
- Its claims are structured to protect both the formulation and treatment method, with variations explicitly covered.
- The patent landscape in Chile revolves around established formulations, with patent applicants needing to demonstrate clear inventive progress over existing art.
- Prior art analysis indicates the patent falls within a mature field with intense international patenting activity.
- The patent lifetime is limited to 20 years from filing, with prior art and prosecution history influencing enforceability.
FAQs
1. Can this Chilean patent be extended to other Latin American countries?
Yes, through regional patent filings like the ARIPO or via PCT applications, assuming the claims meet local patentability standards.
2. How does Chilean patent law handle patent trolls in pharmaceuticals?
Chile’s patent system emphasizes substantive examination, reducing the likelihood of overly broad or non-inventive patents being granted.
3. What is the typical patent term for pharmaceutical patents in Chile?
20 years from the date of filing, with possible extensions only for specific cases under local regulations.
4. Are process patents as enforceable as composition patents in Chile?
Yes, both process and composition patents are protected, provided they meet novelty and inventive step requirements.
5. How does the Chilean patent landscape impact generic drug entry?
Patent expiry or invalidation opens pathways for generics; patent litigation or opposition can delay or prevent market entry.
References
[1] INAPI. (2022). Chilean Patent Law, Law No. 19.039.
[2] World Intellectual Property Organization. (2021). Patent Landscape Report — Pharmaceuticals.
[3] European Patent Office. (2020). Patent search database.
[4] United States Patent and Trademark Office. (2022). Patent application publication data.
[5] Chilean Pharmaceutical Regulation Authority. (2022). Patents and licensing policies.
